Literature DB >> 15488317

Mitochondrial polymporphisms in Parkinson's Disease.

D Otaegui1, C Paisán, A Sáenz, I Martí, M Ribate, J F Martí-Massó, J Pérez-Tur, A López de Munain.   

Abstract

The mtDNA polymorphisms A4336G, A10398G and T4216C have been associated with PD. While A4336G is thought to be a genetic risk factor, A10398G appears to be a protective factor and T4216C is only weakly associated with the disease. In this work we analyzed the association between these three genetic polymorphisms and PD in a Spanish-PD population. The samples were classified by ethnic origin in Basques or other origin. Our analysis confirm the association between A4336G and PD. Our results with A10398G polymorphism highlight the importance of performing the association studies in ethnically homogeneous populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15488317     DOI: 10.1016/j.neulet.2004.08.012

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease.

Authors:  Russell H Swerdlow; Bradley Weaver; Amy Grawey; Connie Wenger; Eric Freed; Bradford B Worrall
Journal:  J Neurol Sci       Date:  2006-06-19       Impact factor: 3.181

Review 2.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

3.  Mitochondrial DNA polymorphisms and the risk of Parkinson's disease in Taiwan.

Authors:  C M Chen; C C Kuan; G-J Lee-Chen; Y R Wu
Journal:  J Neural Transm (Vienna)       Date:  2007-03-15       Impact factor: 3.575

4.  Mitochondrial DNA polymorphisms and haplogroups in Parkinson's disease and control individuals with a similar genetic background.

Authors:  Helen Latsoudis; Cleanthe Spanaki; Grigoris Chlouverakis; Andreas Plaitakis
Journal:  J Hum Genet       Date:  2008-02-20       Impact factor: 3.172

5.  Possible involvement of a mitochondrial translation initiation factor 3 variant causing decreased mRNA levels in Parkinson's disease.

Authors:  Anna Anvret; Caroline Ran; Marie Westerlund; Ann-Christin Thelander; Olof Sydow; Charlotta Lind; Anna Håkansson; Hans Nissbrandt; Dagmar Galter; Andrea Carmine Belin
Journal:  Parkinsons Dis       Date:  2010-06-14

6.  Genetic Screening of the Mitochondrial Rho GTPases MIRO1 and MIRO2 in Parkinson's Disease.

Authors:  Anna Anvret; Caroline Ran; Marie Westerlund; Olof Sydow; Thomas Willows; Lars Olson; Dagmar Galter; Andrea Carmine Belin
Journal:  Open Neurol J       Date:  2012-04-03

7.  Mitochondrial DNA Haplogroups and the Risk of Sporadic Parkinson's Disease in Han Chinese.

Authors:  Ya-Fang Chen; Wan-Jin Chen; Xiao-Zhen Lin; Qi-Jie Zhang; Jiang-Ping Cai; Chia-Wei Liou; Ning Wang
Journal:  Chin Med J (Engl)       Date:  2015-07-05       Impact factor: 2.628

8.  Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease.

Authors:  Gavin Hudson; Mike Nalls; Jonathan R Evans; David P Breen; Sophie Winder-Rhodes; Karen E Morrison; Huw R Morris; Caroline H Williams-Gray; Roger A Barker; Andrew B Singleton; John Hardy; Nicholas E Wood; David J Burn; Patrick F Chinnery
Journal:  Neurology       Date:  2013-05-03       Impact factor: 9.910

9.  Association of primary open-angle glaucoma with mitochondrial variants and haplogroups common in African Americans.

Authors:  David W Collins; Harini V Gudiseva; Benjamin Trachtman; Anita S Bowman; Anna Sagaser; Prithvi Sankar; Eydie Miller-Ellis; Amanda Lehman; Victoria Addis; Joan M O'Brien
Journal:  Mol Vis       Date:  2016-05-16       Impact factor: 2.367

10.  Female genetic distribution bias in mitochondrial genome observed in Parkinson's Disease patients in northern China.

Authors:  Qiaohong Chu; Xiaoguang Luo; Xiaoni Zhan; Yan Ren; Hao Pang
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.